Clinical trial
Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease
NCT05638880 is registered in ClinicalTrials.gov with Mostafa Bahaa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease
- Lead sponsor
- Mostafa Bahaa
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 20, 2022
- Completion date
- December 20, 2025
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.